Kairos Pharma Ltd (AMEX:KAPA) has seen 0.22 million shares traded in the last trading session. The company, currently valued at $10.28M, closed the last trade at $0.61 per share which meant it gained $0.06 on the day or 10.49% during that session. The KAPA stock price is -555.74% off its 52-week high price of $4.00 and 14.75% above the 52-week low of $0.52.

Kairos Pharma Ltd (AMEX:KAPA) trade information

Sporting 10.49% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the KAPA stock price touched $0.61 or saw a rise of 4.69%. Year-to-date, Kairos Pharma Ltd shares have moved -59.87%, while the 5-day performance has seen it change 8.73%. Over the past 30 days, the shares of Kairos Pharma Ltd (AMEX:KAPA) have changed -24.78%.

Kairos Pharma Ltd (KAPA) estimates and forecasts

The company’s shares have lost -64.12% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -23.37% over the past 5 years.

KAPA Dividends

Kairos Pharma Ltd is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.10% shares in the company for having 16.76 shares of worth $10221.0 while later fund manager owns 2.47 shares of worth $1506.0 as of Mar 31, 2025 , which makes it owner of about 0.01% of company’s outstanding stock.